Why is Cuba developing a new pneumococcal vaccine?
The mere fact of being able to tell Cuban families that a new, effective and safe Cuban pneumococcal vaccine will soon be available, work on which has been advancing since 2006, is already more than just “good news.”
Author: Lisandra Fariñas Acosta | lisandra@granma.cu
february 7, 2018 13:02:07
The new vaccine is another guarantee of the well-being of Cuban children. Photo: Ariel Cecilia Lemus
The mere fact of being able to tell Cuban families that a new, effective and safe Cuban pneumococcal vaccine will soon be available, work on which has been advancing since 2006, is already more than just “good news.”
It’s a comforting thought, “after so many years of development of this vaccine candidate, which includes seven serotypes in a single vaccine and, therefore, it is as if we were developing seven vaccines in one. This singularity has made preclinical demonstrations, the pharmaceutical development and clinical demonstration more complex,” Darielys Santana Mederos, biochemistry graduate and general coordinator of the Finlay Institute’s pneumococcal project, told Granma at the recently concluded Cuban Pediatrics Congress, Pediatría 2018.
According to the expert, following the introduction in the country of vaccines against Haemophilus influenzae and meningococci, pneumococcus is now the fundamental pathogen to cause pneumonia and bacterial meningitis in Cuban children. “Therefore, prevention with a vaccine against pneumococci would have a significant impact on reducing the incidence of bacterial pneumonia and meningitis in this population,” she added.
Continue reading Why is Cuba developing a new pneumococcal vaccine?





You must be logged in to post a comment.